Safe Medicine, Safe Care: What You Need to Know About IV Push Medications

Using examples of events that have been reported to the ISMP National Medication Errors Reporting Program (ISMP MERP), data from cost-effectiveness research studies, and first-hand experience shift...

Podcast: Demystifying Immediate Use: What’s NOT Category 1, 2, or 3

Learn from experts on compliance with USP Chapter <797> in all size facilities.

Podcast: Compliance with USP Chapter <797> in Small and Rural Hospitals

Learn from experts on compliance with USP Chapter <797> in small and rural hospitals.

Errors Associated with Oxytocin

Intravenous (IV) oxytocin used antepartum is indicated to induce labor in patients with a medical indication to stimulate or reinforce labor in selected cases of uterine inertia and as an adjunct i...

The Perils of Polypharmacy

The term “polypharmacy” most commonly refers to a situation where a patient is being treated with many, five or more, medications. Patients of all ages may potentially receive many medications. The...

Errors Associated with Paxlovid

Paxlovid was authorized under the emergency use authorization (EUA) by the US Food and Drug Administration (FDA) in December 2021 and is used for mild-to-moderate coronavirus 2019 (COVID-19)  in ad...

Errors Associated with COVID-19 Vaccines

In December 2020, the US Food and Drug Administration (FDA) granted emergency use authorization (EUA) to both the Pfizer-BioNTech and Moderna coronavirus disease 2019 (COVID-19) vaccines. Since the...